The Effects of Picotesla Range Magnetic Fields on Visuospatial Functions in Multiple Sclerosis

References

• Beatty P. A., Gange J. J. Neuropsychological aspects of multiple sclerosis. Journal of Nervous and Mental Disease 1977; 164: 42–50
   PubMed Web of Science ®Google Scholar
• Bhargava V. K., McKean C. M. Role of 5‐hydroxytryptamine in the modulation of acoustic brainstem (far‐field) potentials. Neuropharmacology 1977; 16: 447–449
   PubMed Web of Science ®Google Scholar
• Bhaskar P. A., Vanchilingam S., Bhaskar A., Devaprabhu A., Ganesan R. A. Effect of L‐dopa on visual evoked potential in patients with Parkinson's disease. Neurology 1986; 36: 1119–1121
   PubMed Web of Science ®Google Scholar
• Bodis‐Wollner I., Yak M. D., Mylin L., Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology 1982; 11: 478–483
   PubMed Web of Science ®Google Scholar
• Brownell B., Hughes J. T. The distribution of plaques in the cerebrum in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1962; 25: 315–320
   PubMed Web of Science ®Google Scholar
• Caine E. D., Bamford H. A., Schiffer R. B. A controlled neuropsychological comparison of Huntington's disease and multiple sclerosis. Archives of Neurology 1986; 43: 249–254
   PubMed Web of Science ®Google Scholar
• Charcot J. M. Lectures on the diseases of the nervous system delivered at la salpetriere, G. Sigerson. The New Sydenham Society, London 1877; 194–195
   Google Scholar
• Chiappa K. H., Harrison J. L., Brooks E. B., Young R. R. Brainstem auditory evoked responses in 200 patients with multiple sclerosis. Annals of Neurology 1980; 7: 135–143
   PubMed Web of Science ®Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Critchley M. The parietal lobes. Hafner Publishing Company Inc., New York 1953
   Google Scholar
• Diers W. C., Brown C. C. Psychometric patterns associated with multiple sclerosis. Archives of Neurology and Psychiatry 1950; 63: 760–765
   PubMedGoogle Scholar
• Dyer R. S., Howell W. E., MacPhail R. C. Dopamine depletion slows retinal transmission. Experimental Neurology 1981; 71: 326–340
   PubMed Web of Science ®Google Scholar
• Filley C. M., Heaton R. K., Nelson L. M., Burks J. S., Franklin G. M. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Archives of Neurology 1989; 46: 157–161
   PubMedGoogle Scholar
• Franklin G. M., Nelson L. M., Filley C. M., Heaton R. K. Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology 1989; 46: 162–167
   PubMed Web of Science ®Google Scholar
• Gawel M. J., Das P., Vincent S. Visual and auditory evoked responses in Parkinson's disease. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Kent 1981; 138–146
   Google Scholar
• Goodglass H., Kaplan E. The assessment of aphasia and related disorders. Lea & Febiger, Philadelphia 1972
   Google Scholar
• Gordon H. W., Corbin E. D., Lee P. A. Changes in specialized cognitive functions following changes in hormone levels. Cortex 1986; 22: 399–415
   PubMed Web of Science ®Google Scholar
• Gowers W. R. A manual of diseases of the nervous system2nd Edition. Churchill, London 1893
   Google Scholar
• Grant I., McDonald W. I., Trimble M. R., Smith E., Reed R. Deficient learning and memory in early and middle phases of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1984; 47: 250–255
   PubMed Web of Science ®Google Scholar
• Heaton R. K., Nelson L. M., Thompson D. S. Neuropsychological findings in relapsing remitting and chronic progressive multiple sclerosis. Journal of Consulting Clinical Psychology 1985; 53: 103–110
   PubMed Web of Science ®Google Scholar
• Holder G. E., Bartlett J. R., Bridges P. K., Kantamanei B. D., Curzon G. Correlation between transmitter metabolite concentrations in human ventricular cerebrospinal fluid and pattern visual evoked potentials. Brain Research 1980; 188: 582–586
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Jolma T., Riekkinen P., Rinne U. K. Effects of L‐tryptophan on central indoleamine metabolism and short‐lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Ivnik R. J. Neuropsychological test performance as a function of the duration of MS‐related symptomatology. Journal of Clinical Psychiatry 1978; 39: 304–312
   PubMed Web of Science ®Google Scholar
• Jambor K. L. Cognitive functioning in multiple sclerosis. British Journal of Psychiatry 1969; 115: 765–775
   PubMed Web of Science ®Google Scholar
• Jewesbury E. C. O. Parietal lobe syndromes. Handbook of clinical neurology: localization in clinical neurology, P. J. Vinken, G. W. Bruyn. North‐Holland Publishing Company, Amsterdam 1969; vol. 2: 680–699
   Google Scholar
• Kahana E., Leibowitz U., Alter M. Cerebral multiple sclerosis. Neurology 1971; 21: 1179–1185
   PubMed Web of Science ®Google Scholar
• Kaplan E. The process approach to neuropsychological assessment of psychiatric patients. Journal of Neuropsychiatry 1990; 2: 72–87
   PubMedGoogle Scholar
• Kirk A., Kertesz A. On drawing impairment in Alzheimer's disease. Archives of Neurology 1991; 48: 73–77
   PubMed Web of Science ®Google Scholar
• Kisser W., Harrer G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Kurtzke J. F., Beebe G. W., Nagler B. Studies on the natural history of multiple sclerosis: 6. clinical and laboratory findings at first diagnosis. Acta Neurologica Scandinavica 1972; 48: 19–46
   PubMed Web of Science ®Google Scholar
• Lennon V. A., Carnegie P. R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet 1971; 2: 630–633
   Google Scholar
• Monaco F., Fumero S., Mondino A., Mutani R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 640–641
   PubMed Web of Science ®Google Scholar
• Onofrj M., Bodis‐Wollner I. Dopaminergic deficiency causes delayed visual evoked potentials in rats. Annals of Neurology 1982; 11: 484–490
   PubMed Web of Science ®Google Scholar
• Onofrij M., Bazzano S., Malatesta G., Gambi D. Pathophysiology of delayed evoked potentials in multiple sclerosis. Functional Neurology 1990; 5: 301–319
   PubMedGoogle Scholar
• Rao S. M. Neuropsychology of multiple sclerosis: a critical review. Journal of Clinical and Experimental Neuropsychology 1986; 8: 503–542
   PubMed Web of Science ®Google Scholar
• Rao S. M., Hammeke T. A., McQuillen M. P., Khatri B. O., Lloyd D. Memory disturbance in chronic progressive multiple sclerosis. Archives of Neurology 1984; 41: 625–631
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience, (in press b)
   Google Scholar
• Shulman K., Shedletsky R., Silver I. L. The challenge of time: clock drawing and cognitive functioning in the elderly. International Journal of Geriatric Psychiatry 1986; 1: 135–140
   Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Staples D., Lincoln N. B. Intellectual impairment in multiple sclerosis. Rheumatology & Rehabilitation 1979; 18: 153–160
   PubMedGoogle Scholar
• Stockard J. J., Stockard J. E., Sharbrough F. W. Brainstem auditory evoked potentials in neurology: methodology, interpretation, clinical application. Electrodiagnosis in clinical neurology, M. J. Aminoff. Churchill Livingstone, New York 1980; 370–413
   Google Scholar
• Tuokko H., Hadjistavropoulos T., Miller J. A., Beattie B. L. The clock test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease. Journal of the American Geriatric Society 1992; 40: 579–584
   PubMed Web of Science ®Google Scholar
• White R. F. Emotional and cognitive correlates of multiple sclerosis. Journal of Neuropsychiatry 1990; 2: 422–428
   PubMedGoogle Scholar
• Wolf‐Klein G. P., Silverstone F. A., Levy A. P., Brod M. S. Screening for Alzheimer's disease by clock drawing. Journal of the American Geriatrics Society 1989; 37: 730–734
   PubMed Web of Science ®Google Scholar